dactinomycin has been researched along with Libman-Sacks Disease in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (83.33) | 18.7374 |
| 1990's | 1 (4.17) | 18.2507 |
| 2000's | 3 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aringer, M; Ekhart, H; Feierl, E; Karonitsch, T; Smolen, JS; Steiner, CW; Stummvoll, GH | 1 |
| Russell, DH; Womble, JR | 1 |
| Gabrielsen, AE; Olsen, CT | 2 |
| Gabrielsen, AE; Olsen, CT; Teague, PO | 1 |
| Dang, H; Kong, L; Sakata, A; Sakata, K; Talal, N; Vela-Roch, N | 1 |
| Lin, ML; Liu, WT; Sun, GH; Sun, KH; Tang, SJ; Wang, YS | 1 |
| Cidlowski, J; Datson, NA; de Kloet, ER; Derijk, RH; Detera-Wadleigh, SD; Emery, P; Schaaf, MJ; Sternberg, EM; Turner, G; Vreugdenhil, E | 1 |
| Seipelt, H | 1 |
| Zhdanov, VM | 1 |
| Gabrielsen, AE; Olsen, CT; Rudofsky, UH; Simmons, AD; Urizar, RE | 1 |
| Gabrielsen, AE | 1 |
| Young, BJ | 1 |
| Gabrielsen, AE; Lubert, AS; Olsen, CT | 1 |
| Abe, H; Ishida, M; Iwasaki, T; Kaizuka, H; Mori, S; Satodate, R; Tamura, G | 1 |
| Deguchi, Y; Kishimoto, S; Negoro, S | 1 |
| Brocteur, J; Moens, C | 1 |
| Moens, C | 1 |
| Holtz, G; Martin, H; Schubert, H; Schubert, JC | 1 |
| Drexler, E; Hanson, V; Johnson, GD; Kornreich, HK; Macpherson, GA | 1 |
| Carlsson, SA; Ege, T; Ringertz, NR | 1 |
| Bell, DA; Blomgren, SE; Clark, C; Vaughan, JH | 1 |
| Araujo, FG; Barnett, EV; Gentry, LO; Remington, JS | 1 |
| Agnello, V; Carr, RI; Koffler, D; Kunkel, HG | 1 |
1 trial(s) available for dactinomycin and Libman-Sacks Disease
| Article | Year |
|---|---|
Engulfed cell remnants, and not cells undergoing apoptosis, constitute the LE-cell phenomenon.
Topics: Antibodies, Antinuclear; Apoptosis; Dactinomycin; Female; Gliotoxin; Histones; Hot Temperature; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Necrosis; Nucleic Acid Synthesis Inhibitors | 2007 |
23 other study(ies) available for dactinomycin and Libman-Sacks Disease
| Article | Year |
|---|---|
Transglutaminase may mediate certain physiological effects of endogenous amines and of amine-containing therapeutical agents.
Topics: Amines; Animals; Cardiac Glycosides; Caseins; Dactinomycin; Doxorubicin; gamma-Glutamyltransferase; Glutamine; Growth; Kinetics; Lupus Erythematosus, Systemic; Ornithine Decarboxylase; Putrescine; Receptor, Insulin; Receptors, Adrenergic, beta; Sulfonamides | 1982 |
Dactinomycin treatment of murine lupus erythematosus. II. Dose and schedule of administration.
Topics: Animals; Dactinomycin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Immune Complex Diseases; Kidney Diseases; Lupus Erythematosus, Systemic; Mice; Mice, Inbred NZB; Proteinuria | 1980 |
Late treatment of murine lupus erythematosus with dactinomycin. II. C1 and antibody to DNA.
Topics: Age Factors; Animals; Antibodies, Antinuclear; Complement C1; Dactinomycin; DNA; Female; Lupus Erythematosus, Systemic; Mice; Time Factors | 1981 |
Monocyte rescue of human T cells from apoptosis is CD40/CD154 dependent.
Topics: Antibodies, Blocking; Apoptosis; CD40 Antigens; CD40 Ligand; Cycloheximide; Dactinomycin; Formaldehyde; Humans; In Vitro Techniques; Ligands; Lipopolysaccharide Receptors; Lupus Erythematosus, Systemic; Lymphocyte Activation; Membrane Glycoproteins; Monocytes; Polymers; T-Lymphocytes | 1999 |
Monoclonal antibodies against human ribosomal P proteins penetrate into living cells and cause apoptosis of Jurkat T cells in culture.
Topics: Animals; Antibodies, Monoclonal; Apoptosis; Astrocytes; Autoantibodies; Blotting, Western; Cell Count; Cell Cycle; Dactinomycin; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Humans; Jurkat Cells; Lupus Erythematosus, Systemic; Membrane Proteins; Mice; Protozoan Proteins; Rats; Recombinant Proteins; Ribosomal Proteins | 2001 |
A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis.
Topics: Animals; Arthritis, Rheumatoid; COS Cells; Dactinomycin; DNA; Female; Humans; Lupus Erythematosus, Systemic; Male; Polymorphism, Genetic; Polymorphism, Single-Stranded Conformational; Protein Isoforms; Receptors, Glucocorticoid; Reverse Transcriptase Polymerase Chain Reaction; RNA Splice Sites; RNA Stability; RNA, Messenger; Sequence Analysis, DNA; Transfection | 2001 |
[Drug immunosuppression].
Topics: Alkylating Agents; Anemia, Hemolytic, Autoimmune; Antimetabolites; Arthritis; Arthritis, Juvenile; Asparaginase; Autoimmune Diseases; B-Lymphocytes; Child; Chronic Disease; Colitis, Ulcerative; Dactinomycin; Hepatitis; Humans; Immunosuppressive Agents; Kidney Diseases; Lupus Erythematosus, Systemic; Mitosis; Penicillamine; Plasma Cells; Purpura, Thrombocytopenic; T-Lymphocytes | 1975 |
Integration of viral genomes.
Topics: Animals; Chick Embryo; Culture Techniques; Dactinomycin; DNA, Viral; Humans; Lupus Erythematosus, Systemic; Measles virus; Oncogenic Viruses; RNA Viruses; RNA-Directed DNA Polymerase; Transcription, Genetic | 1975 |
Dactinomycin treatment of murine lupus erythematosus. I. Renal disease and longevity.
Topics: Animals; Antigen-Antibody Complex; Dactinomycin; Disease Models, Animal; Fluorescent Antibody Technique; Glomerulonephritis; Immune Complex Diseases; Lupus Erythematosus, Systemic; Mice; Microscopy, Electron | 1978 |
Late treatment of murine lupus erythematosus with dactinomycin (actinomycin D). I. Course and longevity.
Topics: Animals; Body Weight; Dactinomycin; Female; Lupus Erythematosus, Systemic; Mice; Mice, Inbred Strains; Time Factors | 1979 |
The nature of lupus erythematosus in mice.
Topics: Animals; Antigen-Antibody Complex; Dactinomycin; Disease Models, Animal; Female; Lupus Erythematosus, Systemic; Mice; Propylthiouracil; Rodent Diseases; Vincristine | 1979 |
Detection of antibodies to DNA: studies using tritiated actinomycin D labelled DNA.
Topics: Antibodies; Dactinomycin; DNA; Humans; Lupus Erythematosus, Systemic; Radioimmunoassay; Tritium | 1976 |
Suppression of murine lupus erythematosus by dactinomycin.
Topics: Animals; Dactinomycin; Disease Models, Animal; Erythropoiesis; Female; Hematocrit; Lupus Erythematosus, Systemic; Mice; Proteinuria | 1976 |
[A case report of angiosarcoma of the breast].
Topics: Adult; Breast Neoplasms; Combined Modality Therapy; Dactinomycin; Female; Hemangiosarcoma; Humans; Lupus Erythematosus, Systemic; Prednisolone | 1987 |
Heat-shock protein synthesis by human peripheral mononuclear cells from SLE patients.
Topics: Dactinomycin; Electrophoresis, Polyacrylamide Gel; Gene Expression Regulation; Heat-Shock Proteins; Humans; Leukocytes, Mononuclear; Lupus Erythematosus, Systemic; Molecular Weight; Transcription, Genetic; Transcriptional Activation | 1987 |
Treatment of rheumatoid arthritis with immunosuppressive drugs. I. Clinical study.
Topics: Arthritis, Rheumatoid; Azathioprine; Blood Sedimentation; Dactinomycin; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic | 1965 |
[Rheumatoid arthritis treated by administration of imuran and actinomycin-c].
Topics: Adult; Aged; Arthritis, Rheumatoid; Azathioprine; Dactinomycin; Female; Humans; Lupus Erythematosus, Systemic; Middle Aged | 1965 |
[Immunosuppressive long term therapy of visceral lupus erythematosus].
Topics: Adult; Amides; Antibodies, Antinuclear; Azathioprine; Dactinomycin; Female; Fluorescent Antibody Technique; Humans; Hydrazines; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Mercaptopurine; Methotrexate; Middle Aged; Neutrophils; Prednisone; Toluene | 1970 |
Some immunologic considerations in focal scleroderma and progressive systemic sclerosis in children.
Topics: Adolescent; Antibodies, Anti-Idiotypic; Antibodies, Antinuclear; Arthritis, Juvenile; Child; Child, Preschool; Dactinomycin; Dermatomyositis; DNA; Female; Fluorescent Antibody Technique; Humans; Immunodiffusion; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immunoglobulins; Infant; Lupus Erythematosus, Systemic; Male; Radioimmunoassay; Scleroderma, Localized; Scleroderma, Systemic; Tritium | 1974 |
Immune microfluorimetric analysis of the distribution of species specific nuclear antigens in HeLa-chick erythrocyte heterokaryons.
Topics: Animals; Antigens; Cell Fusion; Cell Nucleolus; Cell Nucleus; Chick Embryo; Dactinomycin; Erythrocytes; Fluorescent Antibody Technique; Fluorometry; HeLa Cells; Humans; Hybrid Cells; Immune Sera; Lupus Erythematosus, Systemic; Methods; Microscopy, Phase-Contrast; Parainfluenza Virus 1, Human; Radiation Effects; RNA; Species Specificity; Time Factors; Ultraviolet Rays | 1971 |
Anti DNA antibody production by lymphoid cells of NZB-W mice and human systemic lupus erythematosus (SLE).
Topics: Animals; Antibody Formation; Antibody-Producing Cells; Bone Marrow; Bone Marrow Cells; Chlorides; Chromium; Dactinomycin; DNA, Single-Stranded; Erythrocytes; Female; Hemolytic Plaque Technique; Humans; Immune Adherence Reaction; Lupus Erythematosus, Systemic; Lymphocytes; Male; Mice; Mice, Inbred NZB; Serum Albumin; Sheep; Spleen; Thymus Gland; Tritium; Ultrasonics | 1973 |
False-positive anti-Toxoplasma fluorescent-antibody tests in patients with antinuclear antibodies.
Topics: Absorption; Adolescent; Adult; Animals; Antibodies, Antinuclear; Arthritis, Rheumatoid; Cattle; Child; Dactinomycin; Deoxyribonucleases; Diagnosis, Differential; DNA; False Positive Reactions; Female; Fluorescent Antibody Technique; Humans; Immune Sera; Immunoglobulin G; Immunoglobulins; Lupus Erythematosus, Systemic; Male; Middle Aged; Nephritis; Rabbits; Ribonucleases; Serologic Tests; Thymus Gland; Toxoplasma; Toxoplasmosis; Tritium | 1971 |
Studies on DNA antibodies using DNA labelled with actinomycin-D (3H) or dimethyl (3H) sulphate.
Topics: Antibodies; Dactinomycin; DNA; Humans; Immunochemistry; Lupus Erythematosus, Systemic; Precipitin Tests; Sulfates; Tritium | 1969 |